References
- Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F. Persistent renal damage after contrastinduced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation 2012;125:3099-107. https://doi.org/10.1161/CIRCULATIONAHA.111.085290
- Rencuzogullari I, Cagdas M, Karakoyun S, et al. Association of Syntax score II with contrast-induced nephropathy and hemodialysis requirement in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J. 2017;48:59-70.
- Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol 2017;6:86-99. https://doi.org/10.5527/wjn.v6.i3.86
- Liang M, Yang S, Fu N. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: a meta-analysis of 15 randomized controlled trials. Medicine (Baltimore) 2017;96:e7384. https://doi.org/10.1097/MD.0000000000007384
- Yun KH, Lim JH, Hwang KB, et al. Effect of high dose rosuvastatin loading before percutaneous coronary intervention on contrast-induced nephropathy. Korean Circ J 2014;44:301-6. https://doi.org/10.4070/kcj.2014.44.5.301